Warfarin in patients with mechanical heart valves | The BMJ
PROACT Xa Trial to Assess Non-Warfarin Anticoagulation After AVR With a Mechanical Valve – Consult QD
Effectiveness and Safety of Rivaroxaban versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and Polypharmacy | SpringerLink
Effectiveness and Safety of Off-label Dosing of Non–vitamin K Antagonist Anticoagulant for Atrial Fibrillation in Asian Patients | Scientific Reports
Rivaroxaban: a fully-subsidised oral anticoagulant
Rivaroxaban noninferior to warfarin in patients with AF, bioprosthetic mitral valve: RIVER
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve | NEJM
PROACT Xa Trial: Mechanical Valve Replacement Without Warfarin
Learn Eliquis and Artificial Heart Valves Don't Mix
Non–Vitamin K Antagonist Oral Anticoagulants for Mechanical Heart Valves | Circulation
NSAMR - National Student Association of Medical Research - The GALILEO Phase 3 RCT of rivaroxaban for post-transcatheter aortic valve replacement (TAVR) anticoagulation has been halted due to a preliminary analysis revealing
Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve–Induced Thrombin Generation - The Annals of Thoracic Surgery
Rivaroxaban
VisualAbstract: Rivaroxaban noninferior to warfarin in patients with atrial fibrillation and bioprosthetic mitral valves | 2 Minute Medicine
Anticoagulation for Mechanical Heart Valves | Arteriosclerosis, Thrombosis, and Vascular Biology
Updated Labeling for Rivaroxaban Related to Patients With Prosthetic Heart Valves - MPR
Heart Valve Replacement – George N. Britt MS, DMD, PA
Usefulness and Safety of Rivaroxaban in Patients Following Isolated Mitral Valve Replacement With a Mechanical Prosthesis - American Journal of Cardiology
PDF) Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study
Rivaroxaban in patients with mechanical heart valves: A pilot study - Thrombosis Research
Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve–Induced Thrombin Generation - The Annals of Thoracic Surgery
Rivaroxaban is Comparable to Warfarin for Bioprosthetic Mitral Valves and AF | DAIC